Cidara Therapeutics (CDTX) News Today → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free CDTX Stock Alerts $0.92 +0.08 (+9.52%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCidara Therapeutics (CDTX) Set to Announce Quarterly Earnings on Thursdaymarketbeat.com - March 20 at 7:46 AMCidara Therapeutics, Inc. (CDTX)finance.yahoo.com - March 17 at 4:10 PMCidara Therapeutics, Inc. (NASDAQ:CDTX) Sees Large Drop in Short Interestmarketbeat.com - March 13 at 3:59 PMInsider Selling: Cidara Therapeutics, Inc. (NASDAQ:CDTX) CFO Sells 18,931 Shares of Stockinsidertrades.com - March 13 at 7:20 AMCidara Therapeutics, Inc. (NASDAQ:CDTX) CFO Sells $12,683.77 in Stockmarketbeat.com - March 12 at 10:43 PMCidara Therapeutics, Inc.edition.cnn.com - March 9 at 9:32 AMCidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association for Cancer Research (AACR) Annual Meeting 2024finance.yahoo.com - March 6 at 11:37 PMCidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association dor Cancer Research (AACR) Annual Meeting 2024globenewswire.com - March 6 at 8:00 AMSteven Cohen's Point72 Adds Cidara Therapeutics to Its Portfoliofinance.yahoo.com - February 15 at 8:07 AMCidara receives $11M milestone payment from partner Mundipharmamsn.com - February 12 at 6:49 PMCidara Therapeutics Gets $11.1M Milestone Payment for Rezzayomarketwatch.com - February 12 at 8:48 AMCidara Receives Milestone Payment From Mundipharma On European Approval Of REZZAYOmarkets.businessinsider.com - February 12 at 8:48 AMCidara Therapeutics Receives $11.14 Million Milestone Payment Following European Approval of REZZAYOfinance.yahoo.com - February 12 at 8:48 AMCidara Therapeutics Granted Nasdaq Listing Extensionmarkets.businessinsider.com - February 10 at 7:55 AMCidara Therapeutics, Inc.: Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adultsfinanznachrichten.de - January 30 at 9:20 AMPalatin to raise ~$10M via securities offeringmsn.com - January 30 at 9:20 AMCidara Therapeutics Gets UK Watchdog's Approval for Invasive Candidiasis Treatmentmarketwatch.com - January 29 at 7:19 PMCidara Therapeutics Shares Up 14% After UK Approval of Invasive Candidiasis Infection Treatmentmarketwatch.com - January 29 at 7:19 PMCidara rallies 13% after hours on UK approval for Rezzayomsn.com - January 29 at 7:19 PMCidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adultsfinance.yahoo.com - January 29 at 7:19 PMCidara Therapeutics : EU Approves Rezzayo For Treatment Of Invasive Candidiasis In Adultsmarkets.businessinsider.com - December 22 at 8:55 AMCidara Therapeutics Announces European Approval of REZZAYO® (rezafungin) for the Treatment of Invasive Candidiasis in Adultsfinance.yahoo.com - December 22 at 8:55 AMCidara Therapeutics Stock (NASDAQ:CDTX) Dividends: History, Yield and Datesbenzinga.com - December 21 at 2:08 PMCidara Therapeutics Presents New Promising Preclincal Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congressfinance.yahoo.com - December 7 at 8:28 AMCidara Therapeutics Announces Completion of Enrollment in Phase 3 Restore Trial of Rezafungin in Chinafinance.yahoo.com - December 6 at 8:25 AMCidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congressfinance.yahoo.com - November 30 at 12:26 PMCidara Therapeutics Named as a San Diego Metro Area Top Workplacefinance.yahoo.com - November 20 at 9:59 AMCidara Therapeutics Presents Preclinical Data on Novel Drug-Fc Conjugate CBO421 at SITC's 38ᵗʰ Annual Meetingbenzinga.com - November 4 at 6:34 PMCidara Therapeutics, Inc.: Cidara Therapeutics Presents Preclinical Data on Novel Drug-Fc Conjugate CBO421 at SITC's 38?? Annual Meetingfinanznachrichten.de - November 3 at 2:48 PMCidara Therapeutics Presents Preclinical Data on Novel Drug-Fc Conjugate CBO421 at SITC’s 38ᵗʰ Annual Meetingfinance.yahoo.com - November 3 at 2:48 PMCidara Therapeutics Inc (CDTX) Reports Q3 2023 Financial Resultsfinance.yahoo.com - November 2 at 11:38 PMCidara Therapeutics (NASDAQ:CDTX) Is In A Strong Position To Grow Its Businessfinance.yahoo.com - October 21 at 1:50 PMMundipharma and Cidara Therapeutics receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults1finance.yahoo.com - October 13 at 1:54 PMCidara Therapeutics, Mundipharma Get CHMP Approval for Rezafunginmarketwatch.com - October 13 at 1:54 PMEd Arce Recommends ‘Buy’ for Cidara Therapeutics: Anticipated REZZAYO Approval and Promising CD388 Candidate Drive Positive Outlookmarkets.businessinsider.com - October 13 at 1:54 PMCidara Therapeutics and Mundipharma receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults(1)finance.yahoo.com - October 13 at 1:54 PMNurix Therapeutics, Inc. (NRIX) Reports Q3 Loss, Misses Revenue Estimatesmsn.com - October 12 at 10:43 PMCidara Therapeutics Presents New Preclinical and Clinical Data on Novel Drug-Fc Conjugate CD388 at IDWeek 2023finance.yahoo.com - October 11 at 10:44 AMCidara Therapeutics, Inc.: Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - September 30 at 7:50 AMCidara Therapeutics to Present New Data on Novel drug-Fc conjugate CD388 at IDWeek 2023finance.yahoo.com - September 27 at 10:38 AMCidara Therapeutics: Reduced Risk Due To Janssen's Decision And Progress In The Oncology Pipelinemsn.com - September 22 at 11:10 PMCidara Therapeutics' (CDTX) Buy Rating Reiterated at HC Wainwrightmarketbeat.com - September 22 at 8:21 AMH.C. Wainwright Sticks to Their Buy Rating for Cidara Therapeutics (CDTX)markets.businessinsider.com - September 22 at 8:10 AMCidara Therapeutics shares fall as chief scientific officer sells ~18K stockmsn.com - September 16 at 11:23 PMInsider Sell: Chief Scientific Officer Leslie Tari Sells 18,469 Shares of Cidara Therapeutics Incfinance.yahoo.com - September 14 at 10:36 AM3 Biotech Gems to Keep on Your Radarstocknews.com - September 11 at 6:03 PMCidara gets a nod from Janssen to continue CD388 flu prevention programmemsn.com - September 7 at 6:39 PMCidara Therapeutics to Host Virtual Research & Development Day on its Cloudbreak® Development Pipeline on September 21, 2023finance.yahoo.com - September 7 at 6:39 PMCidara shares surge 18.5% as J&J unit Janssen takes lead on flu drugproactiveinvestors.com - September 6 at 10:07 PMWhy Is Infectious Diseases Focused Cidara Therapeutics Stock Trading Higher Today?msn.com - September 6 at 10:07 PM Get Cidara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Buy Friday, Sell Monday, No Exceptions (Ad)Every week traders grind it out Monday through Friday… But neglect trading Friday to Monday… Or… “over the weekend” As one professional trader explains, trading over the weekend is one of the most forgiving strategies you can use today. It allows him to sidestep a lot of the midweek volatility. Yet, gives him the opportunity to target some of the markets biggest stock moves. Just recently, he posted a trade on Nordstrom… The trade was published at 3pm on a Friday afternoon and by Monday morning the trade more than doubled. And for the first time in 2024, he’s sharing his strategy for free. CDTX Media Mentions By Week CDTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CDTX News Sentiment▼1.440.60▲Average Medical News Sentiment CDTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CDTX Articles This Week▼21▲CDTX Articles Average Week Get Cidara Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Turnstone Biologics News Today Atara Biotherapeutics News Today Curis News Today Aligos Therapeutics News Today Semper Paratus Acquisition News Today Cognition Therapeutics News Today Tevogen Bio News Today Ikena Oncology News Today AVROBIO News Today Genenta Science News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CDTX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.